found that TXNDC5 was significantly expressed in tumor tissues, including invasive ductal carcinoma of the breast, squamous cell carcinoma of the cervix, squamous cell carcinoma of the esophagus, papillary plasmacytoma of the ovary, and prostate cancer (13). This evidence concerns the gene TXNDC5 and esophageal squamous cell carcinoma.